Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Stephen Watts

Clinical Cardiac Electrophysiology Rockledge, FL Medical Doctor

NPI 1417050642 CMS profile 64177

119 Longwood Ave, Rockledge, FL 32955

Open in the dashboard

General payments

$7,935

264 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$22,605 paid to institutions, not to them · program years 2019–2022

Through program year 2025, Stephen Watts of Rockledge, FL is reported in the CMS Open Payments database as having received $7,935 across 264 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $22,605 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 29th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $758 25
2024 General $805 37
2023 General $944 29
2022 General $1,121 43
2021 General $1,193 47
2020 General $758 24
2019 General $2,355 59

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Stephen Watts
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Stephen Watts were reported at $758. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Stephen Watts Clinical Cardiac Electrophysiology median Middle half National median
2019 $2,355 $2,361 $585–$8,260 $163
2020 $758 $993 $247–$4,351 $114
2021 $1,193 $1,185 $326–$4,739 $132
2022 $1,121 $2,073 $554–$6,789 $149
2023 $944 $2,568 $759–$8,159 $160
2024 $805 $2,557 $703–$7,403 $164
2025 $758 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $1,945 36 payments
  2. Janssen Pharmaceuticals, Inc $1,236 84 payments
  3. Boston Scientific Corporation $1,153 10 payments
  4. Medtronic, Inc. $584 26 payments
  5. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $469 19 payments
  6. Medtronic Vascular, Inc. $427 6 payments
  7. E.R. Squibb & Sons, L.L.C. $297 18 payments
  8. Novartis Pharmaceuticals Corporation $272 15 payments
  9. Boehringer Ingelheim Pharmaceuticals, Inc. $242 9 payments
  10. Sanofi-Aventis U.S. LLC $167 9 payments
  11. Other $1,143 32 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $6,848 260 payments
  2. Travel and Lodging $1,073 3 payments
  3. Education $14 1 payment
Products named General payments · program years 2019–2025
  1. XARELTO $1,213 83 payments
  2. WATCHMAN $999 3 payments
  3. ENSITE $558 7 payments
  4. LifeVest $469 19 payments
  5. Arctic Front $410 5 payments
  6. Precision Xtra system Diabetes Care $313 4 payments
  7. ENTRESTO $247 14 payments
  8. Quadra Assura CRT Defibrillator $227 7 payments
  9. Micra $214 8 payments
  10. Precision Xtra system Diabetes Care $203 2 payments
  11. Other $3,187 115 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 14 drugs

Part D claims

484

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$262,744

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

49.2%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 76 $98,346
Xarelto Rivaroxaban Brand 74 $60,213
Jardiance Empagliflozin Brand 39 $54,785
Entresto Sacubitril/Valsartan Brand 34 $41,235
Dabigatran Etexilate Dabigatran Etexilate Mesylate Brand 15 $4,938
Metoprolol Succinate Generic 74 $1,224
Atorvastatin Calcium Generic 37 $425
Rosuvastatin Calcium Generic 14 $349
Amiodarone Hcl Generic 21 $346
Carvedilol Generic 35 $290

The 10 drugs with the highest cost, of 14 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 66 billing codes

Paid by Medicare

$190,029

Medicare's payments for the services billed

Medicare patients

594

Average age 78

Services billed

1,885

270 women, 324 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 75%
Ischemic heart disease 52%
Arthritis 50%
Heart failure 42%
Diabetes 39%
Chronic kidney disease 38%
COPD 24%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 6 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
XARELTO
  • Janssen Pharmaceuticals, Inc $129
$129 74 —
JARDIANCE
  • Boehringer Ingelheim Pharmaceuticals, Inc. $64
$64 39 —
CAMZYOS
  • E.R. Squibb & Sons, L.L.C. $35
$35 — —
ELIQUIS
  • E.R. Squibb & Sons, L.L.C. $17
  • PFIZER INC. $9
$26 76 —
MULTAQ
  • SANOFI-AVENTIS U.S. LLC $20
$20 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 6 in the dashboard with a free account

Records

264 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record